Tower Health's pharmacy team is spreading its medication delivery service across Pennsylvania, the West Reading, Pa.-based health system said Jan. 9. 

Pharmaceutical companies merging are thought to increase drug prices, but research from Iowa City-based University of Iowa seems to dispel this theory when the mergers are between generic drugmakers. 

The FDA has mandated updated safety labeling for two respiratory syncytial virus vaccines, Pfizer's Abrysvo and GlaxoSmithKline's Arexvy, following the identification of an increased risk of Guillan-Barré syndrome. 

President-elect Donald Trump has threatened to impose "very high tariffs" on Denmark if the country refuses to allow Greenland to become a part of the U.S., The New York Times reported Jan. 8. 

Johnson & Johnson released results from a phase 3 study, showing that the combination of Rybrevant and Lazcluze significantly improved overall survival in patients with advanced non-small cell lung cancer that has specific epidermal growth factor receptor mutations. 

Health System Owned Specialty Pharmacy Alliance (HOSP) has named Tim Affeldt, PharmD, vice president of specialty/infusion operations at Fairview Pharmacy Services, as its new president. 

As Washington implements the nation's most lenient policy allowing pharmacists to prescribe mifepristone, a medication used for abortion, other states are considering following suit, The New York Times reported Jan. 7.

Patients on dialysis who take denosumab face a 36% higher risk for major cardiovascular adverse events than patients who take oral bisphosphonates, according to a study published Jan. 6 in Annals of Internal Medicine.

Fosigotifator, an amyotrophic lateral sclerosis drug developed by Calico Life Sciences, a biotech company backed by Google's parent company Alphabet, failed to meet its primary endpoint, according to topline results from the Healey ALS platform trial. 

A new study found that the widespread use of pharmaceuticals is introducing toxic "forever chemicals" into U.S. waterways, with large municipal wastewater treatment plants unable to effectively filter them out, The Washington Post reported Jan. 7. 

In a move designed to provide continued access to remote healthcare services for millions of Medicare beneficiaries, lawmakers approved a three-month extension of expanded telemedicine coverage, set to last until March 31, The New York Times reported Jan. 6. 

CVS Health has announced that starting this year, all commercial prescriptions dispensed through CVS Pharmacy will be contracted through its new CVS CostVantage reimbursement model. 

Neumora Therapeutics announced that its antidepressant candidate, navacaprant, did not meet the primary endpoint in a Phase 3 study for major depressive disorder. 

Eli Lilly is intervening in a lawsuit filed by a trade group representing compounding pharmacies, aiming to block the FDA's determination that the shortage of its GLP-1 medications, Mounjaro and Zepbound, has ended. 

Of the hundreds of drugs that entered the U.S. market in 2024, GoodRx has named 19 of them as the most notable. 

The FDA has finalized a rule that establishes requirements for nonprescription drug products with additional conditions for nonprescription use (ACNU). 

Pharmacy benefit managers are coming under growing scrutiny as policymakers push for reforms to address their role in rising drug prices, The Wall Street Journal reported Dec. 30. 

Samaritan Health Services will open a neighborhood pharmacy at Samaritan North Lincoln Hospital in Lincoln City, Ore., on Jan. 6. 

Here are five drug recalls the FDA reported in December: 

President-elect Donald Trump's proposal to increase tariffs on products from Mexico, Canada and China could increase pharmaceutical costs and disrupt supply, The Hill reported Dec. 31.